# Mix Vaccine for Metastatic Kidney Cancer

> **NCT03357289** · PHASE1,PHASE2 · COMPLETED · sponsor: **Fuda Cancer Hospital, Guangzhou** · enrollment: 30 (actual)

## Conditions studied

- Metastasis From Malignant Tumor of Kidney (Disorder)
- Reaction - Mixed Vaccine

## Interventions

- **BIOLOGICAL:** Mix vaccine

## Key facts

- **NCT ID:** NCT03357289
- **Lead sponsor:** Fuda Cancer Hospital, Guangzhou
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-30
- **Primary completion:** 2018-11-30
- **Final completion:** 2019-08-30
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2019-09-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03357289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03357289, "Mix Vaccine for Metastatic Kidney Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03357289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*